Literature DB >> 7221194

Lung function in cystic fibrosis: acute effect of salbutamol.

E Svenonius, M Arborelius, R Kautto, R Kornfält, T Lindberg.   

Abstract

Pulmonary function tests including spirometry, N2 washout and volume of trapped gas (VTG) were obtained in 12 children with cystic fibrosis (CF), 6-18 years of age, before and after inhalation of 0.2 mg salbutamol. 11 children had pathologically increased VTG while the lung clearance index (LCI) was abnormal in 9, V'max 25/TLC (maximal flow at 25% of vital capacity/total lung capacity) in 8, residual volume in 6, but FEV1 in only 2 children. VTG/TLC% increased with age while V'max 25/TLC and FEV1 did not change. Neither was clinical score related to age in our subjects. No improvement in lung function occurred after salbutamol inhalation. VTG proved most sensitive for showing abnormality in children with CF.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7221194     DOI: 10.1159/000194281

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  2 in total

Review 1.  Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.

Authors:  S P Conway; A Watson
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

2.  Plasma concentrations and effects of salbutamol administered orally to patients with cystic fibrosis.

Authors:  R Demnati; M C Michoud; A Jeanneret-Grosjean; H Ong; P Du Souich
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.